View Author
Coelingh Bennink, H.J.
( H.J. Coelingh Bennink)
embryo follicle cycle oocyte study effect antagonist pregnancy org 31710 cryopreservation hormone transfer org 31710 group ovulation blastocyst group concentration stimulation development oestradiol reprod stage endometrial progesterone factor fertil treatment endometrial thickness culture activity steril administration placebo patient follicle development receptor difference gnrh antagonist women protocol contraception in-vitro embryo cryopreservation infertility agonist gnrh antagonists fertilization growth blastocyst stage embryo transfer serum procedure regimen desogestrel result pregnancy rates hyperstimulation syndrome number mifepristone pregnancy rate blastocyst transfer thickness problem diameter anti-progestagen couple gnrh agonist ovary hyperstimulation parameter outcome endometrium implantation suppression alternative progesterone concentrations luteinizing granulosa pituitaryovarian quality
3 Most Recent Publications
|
Alternative approaches in IVF
(Article)
Fauser, B.C.J.M. Bouchard, P. Coelingh Bennink, H.J. Collins, J.A. Devroey, P. Evers, J.L.H. Steirteghem, A. van |
2002-01-01
|
|
Single monthly administration of the anti-progestagen Org 31710 in users of the 75 microg desogestrel progestagen-only pill: effects on pituitary-ovarian activity
(Article)
Heusden, A.M. van Killick, S.R. Coelingh Bennink, H.J. Fauser, B.C.J.M. |
2000-01-01
|
|
High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization
(Article)
Jong, D. de Macklon, N.S. Mannaerts, B.M. Coelingh Bennink, H.J. Fauser, B.C.J.M. |
1998-01-01
|
